ACE Inhibitors
ACE Inhibitors
Agent
Oral
Initial Daily Dose
Bioavailability (%)
Loop Diuretics (inhibit 20%25% of sodium reabsorption)
Maximal Total
Daily Dose (mg)
Duration of Action
(hr)
Furosemideb
1067
600
68
Bumetanideb
80100
10
46
Torsemideb
Ethacrynic acidb
80100
100
1020 mg daily
2550 mg once or
twice daily
Thiazide Diuretics (inhibit 10%15% of sodium reabsorption)
200
200
1216
Hydrochlorothiazide
6575
100
612
Metolazone
Chlorthalidone
Chlorothiazideb
4065
64
3050
20
100
2000
1224
2472
612
2040 mg once or
twice daily
0.51 mg once or
twice daily
25 mg once or twice
daily
2.5 mg daily
12.525 mg daily
250500 once or
twice daily
ACE inhibitors
ACE Inhibitors and Recommended Dosing
Drug
Captopril
Enalapril
Lisinopril
Perindopril
Ramipril
Trandolapril
Starting Dosage
6.25 mg TID
2.5 mg BID
2.55 mg/day
2 mg/day
1.252.5 mg/day
1 mg/day
Target Dosage
50 mg TID
10 mg BID
20 mg/day
8 mg/day
10 mg/day
4 mg/day
Maximal Dosage
50 mg TID
20 mg BID
40 mg/day
16 mg/day
10 mg/day
4 mg/day
Note: Fosinopril and quinapril may be used; however, they do not have the same magnitude of mortality-reducing data as listed above.
ACE = angiotensin-converting enzyme; BID = twice daily; TID = three times daily.
i.
(d)
(e) Avoid use in patients who have experienced angioedema or
those who are pregnant or plan to become pregnant.
(f) Use caution if systolic BP is less than 80 mm Hg, SCr is greater
than 3 mg/dL, or elevated K is greater than 5.0 mEq/L or in
bilateral renal artery stenosis.
(g)
(h)
(i) ARBs and Recommended Dosing
(j)
(k) Drug
Starting Dosage
(n) Candesartan
(o) 48 mg/day
(q) Losartan
(r) 2550 mg/day
Valsartan
(u) 2040 mg BID
(w)
(x)
(y) -Blockers and Recommended
Dosing
(z)
(aa)Agent
(ad) Bisoprolol
(ag) Carvedilol
(aj) Carvedilol CR
Metoprolol succinate XLb (metoprolol (an) 12.525 mg/day (ao) 200 mg/day
a CR/XL)
50 mg twice daily if weight is more than 85 kg.
(am)
(ap)
(aq) bLittle or no data exists for metoprolol tartrate.
(ar) BID = twice daily; CR = controlled release; XL = extended release.
(as)
(at)
(au) Dosing of Aldosterone Antagonists
(av)
(aw) Parameters
(az) Estimated CrCl >50 mL/minute and
K 5 mEq/L
(bc) Maintenance dose after 1 month if
(bd) K 5 mEq/L and CrCl > 50 mL/minute
(bg) Estimated CrCl 3040 mL/minute
(ax) Eplerenone
(ba) 25 mg once daily
(ay) Spironolactone
(bb) 12.525 mg once daily
(bm)